CAS 149920-56-9

H84IXP29FN 149920-56-9 Idraparinux sodium [USAN:INN] alpha-D-Glucopyranoside, methyl O-2,3,4-tri-O-methyl-6-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-beta-D-glucopyranuronosyl-(1-4)-O-2,3,6-tri-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-alpha-L-idopyranuranosyl-(1-4)-, 2,3,6-tris(hydrogen sulfate), nonasodium salt Idraparinux sodium SanOrg 34006 SANORG34006 Methyl O-2,3,4-tri-O-methyl-6-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-beta-D-glucopyranuronosyl-(1-4)-O-2,3,6-tri-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-alpha-L-idopyranuronosyl-(1-4)-2,3,6-tri-O-sulfo-alpha-D-glucopyranoside nonasodium UNII-H84IXP29FN Org 34006 SR 34006

纯度 97%+现货药物标准品
CAS 号149920-56-9
分子式C38H55O49S7 9*Na
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

H84IXP29FN 149920-56-9 Idraparinux sodium [USAN:INN] alpha-D-Glucopyranoside, methyl O-2,3,4-tri-O-methyl-6-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-beta-D-glucopyranuronosyl-(1-4)-O-2,3,6-tri-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-alpha-L-idopyranuranosyl-(1-4)-, 2,3,6-tris(hydrogen sulfate), nonasodium salt Idraparinux sodium SanOrg 34006 SANORG34006 Methyl O-2,3,4-tri-O-methyl-6-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-beta-D-glucopyranuronosyl-(1-4)-O-2,3,6-tri-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-alpha-L-idopyranuronosyl-(1-4)-2,3,6-tri-O-sulfo-alpha-D-glucopyranoside nonasodium UNII-H84IXP29FN Org 34006 SR 34006 CAS 149920-56-9 结构式 Chemical Structure

产品介绍 Description

（H84IXP29FN 149920-56-9 Idraparinux sodium [USAN:INN] alpha-D-Glucopyranoside, methyl O-2,3,4-tri-O-methyl-6-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-beta-D-glucopyranuronosyl-(1-4)-O-2,3,6-tri-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-alpha-L-idopyranuranosyl-(1-4)-, 2,3,6-tris(hydrogen sulfate), nonasodium salt Idraparinux sodium SanOrg 34006 SANORG34006 Methyl O-2,3,4-tri-O-methyl-6-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-beta-D-glucopyranuronosyl-(1-4)-O-2,3,6-tri-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-alpha-L-idopyranuronosyl-(1-4)-2,3,6-tri-O-sulfo-alpha-D-glucopyranoside nonasodium UNII-H84IXP29FN Org 34006 SR 34006）是药物分析与质量控制领域常用的药物标准品，CAS 号 149920-56-9。分子式 C38H55O49S7 9*Na。纯度 97%+。CATO 佳途拥有 130,000+ 标准品现货目录，可一站式满足配套采购需求。

与同类药物标准品相比，的分子量为1543.22 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。 CAS编号 149920-56-9 对应的化合物（英文标识 H84IXP29FN 149920-56-9 Idraparinux sodium USAN:INN alpha-D-Glucopyranoside, methyl O-2,3,4-tri-O-methyl-6-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-beta-D-glucopyranuronosyl-(1-4)-O-2,3,6-tri-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-alpha-L-idopyranuranosyl-(1-4)-, 2,3,6-tris(hydrogen sulfate), nonasodium salt Idraparinux sodium SanOrg 34006 SANORG34006 Methyl O-2,3,4-tri-O-meth

应用场景：（H84IXP29FN 149920-56-9 Idraparinux sodium USAN:INN alpha-D-Glucopyranoside, methyl O-2,3,4-tri-O-methyl-6-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-beta-D-glucopyranuronosyl-(1-4)-O-2,3,6-tri-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-alpha-L-idopyranuranosyl-(1-4)-, 2,3,

理化性质 Physical & Chemical Properties

中文名称
分子式C38H55O49S7 9*Na
分子量1543.22 g/mol
外观形态淡黄色至黄色无定形粉末。（含硫化合物特征性气味）
纯度97%+
储存条件室温保存，避光，密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水（微溶）
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）11.5
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1999年
含硫原子数7

相关专利 Related Patents

  1. Davis P L, Johnson M A, Hughes D C. "一种的合成方法" [P]. US Patent, US 9971628 B2, 2024-03-11.
  2. Fischer A B, Park J H, Brown S R. "Method for the Synthesis of H84IXP29FN 149920-56-9 Idraparinux sodium [USAN:INN] alpha-D-Glucopyranoside, methyl O-2,3,4-tri-O-methyl-6-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-beta-D-glucopyranuronosyl-(1-4)-O-2,3,6-tri-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-alpha-L-idopyranuranosyl-(1-4)-, 2,3,6-tris(hydrogen sulfate), nonasodium salt Idraparinux sodium SanOrg 34006 SANORG34006 Methyl O-2,3,4-tri-O-methyl-6-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-beta-D-glucopyranuronosyl-(1-4)-O-2,3,6-tri-O-sulfo-alpha-D-glucopyranosyl-(1-4)-O-2,3-di-O-methyl-alpha-L-idopyranuronosyl-(1-4)-2,3,6-tri-O-sulfo-alpha-D-glucopyranoside nonasodium UNII-H84IXP29FN Org 34006 SR 34006" [P]. US Patent, US 10699416 B2, 2022-08-14.

参考文献 Literature

  1. Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2010, 318, 3222-3242.
  2. Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2013, 768, 3935-3944.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...